Literature DB >> 16856207

IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.

Caterina Lapenta1, Stefano M Santini, Massimo Spada, Simona Donati, Francesca Urbani, Daniele Accapezzato, Debora Franceschini, Mauro Andreotti, Vincenzo Barnaba, Filippo Belardelli.   

Abstract

Dendritic cells (DC) generated after a short-term exposure of monocytes to IFN-alpha and GM-CSF (IFN-DC) are highly effective in inducing cross-priming of CD8(+ )T cells against viral antigens. We have investigated the mechanisms responsible for the special attitude of these DC and compared their activity with that of reference DC. Antigen uptake and endosomal processing capabilities were similar for IFN-DC and IL-4-derived DC. Both DC types efficiently cross-presented soluble HCV NS3 protein to the specific CD8(+) T cell clone, even though IFN-DC were superior in cross-presenting low amounts of viral antigens. Moreover, when DC were pulsed with inactivated HIV-1 and injected into hu-PBL-SCID mice, the generation of virus-specific CD8(+ )T cells was markedly higher in animals immunized with IFN-DC than in mice immunized with CD40L-matured IL-4-DC. Of interest, in experiments with purified CD8(+ )T cells, IFN-DC were superior with respect to CD40L-matured IL-4-DC in inducing in vitro cross-priming of HIV-specific CD8(+ )T cells. This property correlated with enhanced potential to express the specific subunits of the IL-23 and IL-27 cytokines. These results suggest that IFN-DC are directly licensed for an efficient CD8(+) T cell priming by mechanisms likely involving enhanced antigen presentation and special attitude to produce IL-12 family cytokines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16856207     DOI: 10.1002/eji.200535579

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  57 in total

1.  Clinical reagents of GM-CSF and IFN-α induce the generation of functional chronic myeloid leukemia dendritic cells in vitro.

Authors:  Kaizhi Weng; Xiaobao Xie; Guoqiang Qiu; Weiying Gu
Journal:  Cytotechnology       Date:  2011-09-22       Impact factor: 2.058

Review 2.  The role of type I interferon production by dendritic cells in host defense.

Authors:  P Fitzgerald-Bocarsly; D Feng
Journal:  Biochimie       Date:  2007-05-08       Impact factor: 4.079

Review 3.  Exploiting dendritic cells for active immunotherapy of cancer and chronic infections.

Authors:  David W O'Neill; Nina Bhardwaj
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

Review 4.  New players in cytokine control of HIV infection.

Authors:  Massimo Alfano; Andrea Crotti; Elisa Vicenzi; Guido Poli
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

Review 5.  DC-based cancer vaccines.

Authors:  Eli Gilboa
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

6.  Vesicular stomatitis virus M protein mutant stimulates maturation of Toll-like receptor 7 (TLR7)-positive dendritic cells through TLR-dependent and -independent mechanisms.

Authors:  Maryam Ahmed; Latoya M Mitchell; Shelby Puckett; Kristina L Brzoza-Lewis; Douglas S Lyles; Elizabeth M Hiltbold
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

7.  Sorafenib and a novel immune therapy in lung metastasis from hepatocellular carcinoma following hepatectomy: A case report.

Authors:  Yongxiang Yi; Jianbo Han; Yuan Fang; Dongxiao Liu; Zuoyou Wu; Lili Wang; Liang Zhao; Qiang Wei
Journal:  Mol Clin Oncol       Date:  2016-06-10

8.  Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens.

Authors:  Fabio Morandi; Lizzia Raffaghello; Giovanna Bianchi; Francesca Meloni; Annalisa Salis; Enrico Millo; Soldano Ferrone; Vincenzo Barnaba; Vito Pistoia
Journal:  Stem Cells       Date:  2008-02-21       Impact factor: 6.277

9.  Primary human immunodeficiency virus type 1-specific CD8+ T-cell responses induced by myeloid dendritic cells.

Authors:  Bonnie A Colleton; Xiao-Li Huang; Nada M Melhem; Zheng Fan; Luann Borowski; Giovanna Rappocciolo; Charles R Rinaldo
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

10.  LPS and poly I:C induce chromatin modifications at a novel upstream region of the IL-23 p19 promoter.

Authors:  Stacey Garrett; Michael C Fitzgerald; Kathleen E Sullivan
Journal:  Inflammation       Date:  2008-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.